Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Clinical Criteria You Must Meet BCBSNC's medical policy generally mirrors the FDA-approved indication for Wegovy and aligns with 2024 guidance from the American Association of Clinical Endocrinology (AACE) on anti-obesity pharmacotherapy [3]
Your tirzepatide dose is measured by the weight of active medication (in milligrams) before the pen is filled, not by total liquid volume
These benefits make semaglutide a valuable treatment option for those at risk of cardiovascular disease due to obesity
For further assistance, please connect with our analysts
US$ 28.97
US$ 29.79
US$ 23.94
